Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein H1 (FOXH1) is a DNA-binding transcription factor of the forkhead box (FOX) family characterized by a winged helix domain. It recognizes specific DNA motifs—primarily TGT(G/T)(T/G)ATT—via a unique, extended FH domain fold, which differentiates it from other FOX proteins. FOXH1 functions as a critical regulator of mesendoderm specification and anterior-posterior patterning during embryogenesis, including node formation and cardiac development. It acts as a pioneer factor that binds chromatin even in the context of nucleosomes, facilitating activin and TGF-beta signal transduction through interaction with SMAD2 and SMAD4 to regulate target genes such as goosecoid (GSC). FOXH1 has documented roles in both development and disease, with mutations or dysregulation linked to developmental disorders and elevated expression associated with certain cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein H1 (FOXH1).